Incidence and Survival of Patients with Small Intestinal Neuroendocrine Tumours in a Danish NET Center

Table 3

Imaging modalities performed at referral.

	Group 1	Group 2	𝑃 value
CT scanning	38.5% (20/52)	78.9% (86/109)	0.000
Octreotide scintigraphy	78.8% (41/52)	74.3% (81/109)	0.530
MRI scanning	1.9% (1/52)	4.6% (5/109)	0.404
PET scanning	0.0% (0/52)	23.9% (26/109)	0.000